inVentiv Health (VTIV) Misses Q3 EPS by 9c
More News related to VTIV
- FDA Official States Need for Greater Data from Public Stakeholders and Industry to Inform the Guidance Process for use of Internet and Social Media in the Promotion of FDA-regulated Medical Products
- inVentiv Health to Announce Fourth Quarter and 2009 Full-Year Results and Conduct Conference Call on February 24
- inVentiv Selling Solutions Launches New Model for Outsourcing Sales
- 'Wednesday FoREMS' Webinar to Examine Managing Lifecycle of REMS Implementation
- inVentiv Health to Present at UBS 20th Annual Global Healthcare Services Conference
More News related to Earnings
- Dean Foods (DF) Reports Q4 Adj-EPS of $0.31, Misses by 6c; Guides Q1, FY10
- Asure Software, Inc. (ASUR) Reports for the Two- and Five-Months Ended December 31, 2009
- Louisiana-Pacific (LPX) Posts Q4 Loss of $0.38, Wider than Expectations
- Lionbridge (LIOX) Reports Q4 Adj-EPS of $0.12; Guides Q1 Sales, Reaffirms FY10 Outlook
- China Advanced Construction Materials (CADC) Posts Q2 adj.-EPS of $0.35, Better Y/Y; Revs Heavy
inVentiv Health, Inc. (Nasdaq: VTIV) reports Q3 EPS of $0.34, 9 cents below the analyst estimate of $0.43. Revenue for the quarter was $270.5 million, which compares to the estimate of $300 million.
Related Categories
EarningsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
